Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-14 · accession 0001415889-24-016995 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-14 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -15.0K | 5,022 | -75% | -$375.4K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +15.0K | 20.0K | +299% | +$32.1K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -15.0K | 28.8K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | S | D | 15,000 | $25.03 | 5,022 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-14 | M | A | 15,000 | $2.14 | 20,022 | D | — | — | (F2) Includes 3,062 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d). |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-06-14 | M | D | 15,000 | $0.00 | 28,763 | D | $2.14 · — to 2031-04-01 | 15,000 Common Stock | (F3) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |